MedTrace Logo

Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery

NCT00091962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 453

Last updated 2016-04-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to treat depression in patients who have undergone coronary artery bypass graft (CABG).

Conditions

Interventions

BEHAVIORAL

Psychoeducation; Treatment recommendations

Counseling program

DRUG

Pharmacotherapy

Recommendations to patients' PCP for medication to treat depression

OTHER

Usual Care

Physicians' Usual care

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Bruce L. Rollman · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2008-06-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00091962 on ClinicalTrials.gov